LAST LAUGH: Family doctors' favourite things BREAST CANCER: Zoledronic acid may help reduce tumours Depression front-runner New-generation antidepressant sertraline has best balance between benefits, acceptability and cost Antiplatelet response is in the genes But genetic testing isn't ready yet, MDs say The future of hospital pharmacy Pharmacists must embrace change and communicate the essence of their profession in a high-tech world or risk being seen as dispensable. Clopidogrel's interactions with other drugs, genetics to be studied BREAST CANCER: Lapatinib helps control metastatic breast cancer Biologic agent added to aromatase inhibitor New guide for palliative caregivers A revised source of information and a practical tool for helping people live through the suffering often experienced at end of life. Olmetec: new angiotensin II blocker coming soon Schering-Plough will soon be launching Olmetec and Olmetec Plus for the treatment of mild to moderate hypertension. B.C. drug substitution plan cost more than it saved: study First Previous 1251 1252 1253 1254 1255 Next Last
